Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX 77030, USA.
Genet Med. 2011 Nov;13(11):948-55. doi: 10.1097/GIM.0b013e3182227589.
Despite growing concerns toward maintaining participants' privacy, individual investigators collecting tissue and other biological specimens for genomic analysis are encouraged to obtain informed consent for broad data sharing. Our purpose was to assess the effect on research enrollment and data sharing decisions of three different consent types (traditional, binary, or tiered) with varying levels of control and choices regarding data sharing.
A single-blinded, randomized controlled trial was conducted with 323 eligible adult participants being recruited into one of six genome studies at Baylor College of Medicine in Houston, Texas, between January 2008 and August 2009. Participants were randomly assigned to one of three experimental consent documents (traditional, n = 110; binary, n = 103; and tiered, n = 110). Debriefing in follow-up visits provided participants a detailed review of all consent types and the chance to change data sharing choices or decline genome study participation.
Before debriefing, 83.9% of participants chose public data release. After debriefing, 53.1% chose public data release, 33.1% chose restricted (controlled access database) release, and 13.7% opted out of data sharing. Only one participant declined genome study participation due to data sharing concerns.
Our findings indicate that most participants are willing to publicly release their genomic data; however, a significant portion prefers restricted release. These results suggest discordance between existing data sharing policies and participants' judgments and desires.
尽管人们越来越关注维护参与者的隐私,但鼓励收集组织和其他生物标本进行基因组分析的个别研究人员获得广泛数据共享的知情同意。我们的目的是评估三种不同的同意类型(传统型、二进制型或分层型)对研究招募和数据共享决策的影响,这些同意类型在数据共享方面具有不同程度的控制和选择。
这是一项单盲、随机对照试验,于 2008 年 1 月至 2009 年 8 月在德克萨斯州休斯顿的贝勒医学院(Baylor College of Medicine)进行,共招募了 323 名符合条件的成年参与者进入 6 项基因组研究之一。参与者被随机分配到三种实验性同意文件之一(传统型,n = 110;二进制型,n = 103;分层型,n = 110)。在后续随访中,对参与者进行了详细的告知,提供了所有同意类型的详细信息,并让他们有机会更改数据共享选择或拒绝参与基因组研究。
在告知之前,83.9%的参与者选择公开数据发布。告知后,53.1%的参与者选择公开数据发布,33.1%的参与者选择限制(受控访问数据库)发布,13.7%的参与者选择不共享数据。只有一名参与者因数据共享问题而拒绝参与基因组研究。
我们的研究结果表明,大多数参与者愿意公开发布他们的基因组数据;然而,相当一部分人更倾向于限制发布。这些结果表明,现有的数据共享政策与参与者的判断和愿望之间存在不一致。